GSK, Theravance asthma drug shows improved lung function in study

December 6, 2013 2:02 PM

7 0

GSK, Theravance asthma drug shows improved lung function in study

(Reuters) - GlaxoSmithKline and Theravance Inc said on Friday that their combination therapy met the main goal of improving lung function in asthma patients in a late-stage trial.

The therapy consists of the corticosteroid, fluticasone furoate, which reduces inflammation, and a long-acting beta-agonist, called vilanterol, which is designed to open the airways.

Read more

To category page

Loading...